BAP1 genetic testing among melanoma and cancer-prone families in Sweden

Hildur Helgadottir^{1

2}, Karina Schultz^{1

2}, Jan Lapins^{3

4}, Ismini Vassilaki⁵, Charlotta All-Eriksson⁶, Veronica Höiom^{1

2}

Affiliations

¹ Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
² Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
⁴ Dermatology and Venereology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Pathology, Karolinska University Hospital, Stockholm, Sweden.
⁶ Department of Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Hildur Helgadottir et al. Acta Oncol. 2023 Jun.

. 2023 Jun;62(6):565-570.

doi: 10.1080/0284186X.2023.2216338. Epub 2023 Jun 2.

Hildur Helgadottir^{1

2}, Karina Schultz^{1

2}, Jan Lapins^{3

4}, Ismini Vassilaki⁵, Charlotta All-Eriksson⁶, Veronica Höiom^{1

2}

¹ Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
² Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
⁴ Dermatology and Venereology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Pathology, Karolinska University Hospital, Stockholm, Sweden.
⁶ Department of Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden.

No abstract available

MeSH terms